EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Profile of Antimicrobial Consumption in Patients Assisted by a Palliative Care Team During the COVID-19 Pandemic in Brazil

Tulio L Correa iD, Matheus Ac Quitete, Clara Rs do Nascimento, Rafaela P Carbone, Ricardo T de Carvalho, Juraci A Rocha

American Journal of Hospice and Palliative Medicine® · 2024

DOI: 10.1177/10499091231215432 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Hospice and Palliative Medicine®, 2024. Verfasst von Tulio L Correa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Palliative Care Team, Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Palliative Care, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the profile of antimicrobial consumption in patients assisted by a palliative care (PC) team during the COVID-19 pandemic.

Methods

A retrospective observational study was conducted in a quaternary hospital. Patients assisted by the PC team in 2020 were selected. The clinical and demographic characteristics, as well as the outcomes, were assessed using electronic records.

Results

A total of 181 patients were included in the study, of whom 93.4% had used antimicrobials and 24.3% had had COVID-19. COVID-19 patients were more likely to receive at least one course of antimicrobial therapy. Patients who received polytherapy in the first course of treatment were more likely to die and to be still receiving antimicrobials at death. There was no significant difference in the length of hospital stay, new hospitalization in 12 months, nor the time to death among patients who received monotherapy or polytherapy during the first course of antimicrobial therapy.

Conclusions

There was a large amount of PC patients receiving antimicrobial therapy during the COVID-19 pandemic. SARS-CoV-2-positive patients were more likely to receive antimicrobial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palliative CareCOVID-19HumansMaleFemaleRetrospective StudiesBrazilMiddle AgedAgedAnti-Infective AgentsAged, 80 and overAdultSARS-CoV-2Length of Stay

Stichwörter der Autor:innen

COVID-19anti-infective agentsantibioticsantimicrobial agentpalliative carepandemic

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Palliative Care Team, Hospital das Clínicas, Faculty of Medicine, Universidade de São Paulo, Sao Paulo, Brazil.

ORCID-Profile: Tulio L Correa

Zitieren

APA

Correa, T. L., Quitete, M. A., do Nascimento, C. R., Carbone, R. P., de Carvalho, R. T., & Rocha, J. A. (2024). Profile of Antimicrobial Consumption in Patients Assisted by a Palliative Care Team During the COVID-19 Pandemic in Brazil. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091231215432

Vancouver

Correa TL, Quitete MA, do Nascimento CR, Carbone RP, de Carvalho RT, Rocha JA. Profile of Antimicrobial Consumption in Patients Assisted by a Palliative Care Team During the COVID-19 Pandemic in Brazil. American Journal of Hospice and Palliative Medicine®. 2024. doi:10.1177/10499091231215432

BibTeX
@article{Correa2024,
  author = {Correa, Tulio L and Quitete, Matheus Ac and do Nascimento, Clara Rs and Carbone, Rafaela P and de Carvalho, Ricardo T and Rocha, Juraci A},
  title = {Profile of Antimicrobial Consumption in Patients Assisted by a Palliative Care Team During the COVID-19 Pandemic in Brazil},
  journal = {American Journal of Hospice and Palliative Medicine®},
  year = {2024},
  doi = {10.1177/10499091231215432}
}
Kostenlos starten →